https://scholars.lib.ntu.edu.tw/handle/123456789/613368
Title: | RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability | Authors: | Nadal E. Horinouchi H. JIN-YUAN SHIH Nakagawa K. Reck M. Garon E.B. Wei Y.-F. Kollmeier J. Frimodt-Moller B. Barrett E. Lipkovich O. Visseren-Grul C. Novello S. |
Issue Date: | 2022 | Publisher: | Adis | Journal Volume: | 45 | Journal Issue: | 1 | Start page/Pages: | 45-64 | Source: | Drug Safety | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121456404&doi=10.1007%2fs40264-021-01127-2&partnerID=40&md5=76b47e3dc1a2850142f91402a226ede8 https://scholars.lib.ntu.edu.tw/handle/123456789/613368 |
ISSN: | 0114-5916 | DOI: | 10.1007/s40264-021-01127-2 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.